Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developmental changes in soluble CD40 ligand.

Jill M Cholette1, Neil Blumberg, Richard P Phipps

  • 1Department of Pediatrics, University of Rochester Medical Center, Rochester, New York 14642, USA.

The Journal of Pediatrics
|December 25, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vamorolone for Duchenne Muscular Dystrophy: A Cross-Trial Efficacy Comparison With Classic Corticosteroids From the FOR-DMD Trial.

Neurology·2026
Same author

Neurobehavioral Profiles in Young Steroid-Naive Boys With Duchenne Muscular Dystrophy: A Baseline Data Analysis From the FOR-DMD Trial.

Neurology·2026
Same author

Prophylactic half-dose platelet transfusion effect on thrombocytopenia, transfusion, and bleeding occurrence in patients with hematologic disease.

American journal of clinical pathology·2026
Same author

The case for washing red blood cells and platelets - A concise review of donors, processes, and products.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same author

Mobile EEG assessment of inhibitory control during dual-task walking in Parkinson's disease.

Parkinsonism & related disorders·2026
Same author

Pet-directed speech strengthens the veterinarian-client-patient relationship: Results from a pet owner survey.

The Veterinary record·2026
Same journal

Time-to-Transfer and Hospitalization Duration for Severe Congenital Heart Defects: Implications for Perinatal Regionalization.

The Journal of pediatrics·2026
Same journal

Multimodal neuromonitoring in neonatal hypoxic-ischemic encephalopathy and the association with neurodevelopmental outcomes: A Multicenter Study.

The Journal of pediatrics·2026
Same journal

KP.2-Adapted BNT162b2 COVID-19 Vaccine Uptake and Effectiveness in Children.

The Journal of pediatrics·2026
Same journal

Respiratory Syncytial Virus Immunization Disparities in Mothers and Infants at the Birth Hospitalization: A Cross-Sectional Study.

The Journal of pediatrics·2026
Same journal

Blood-Based Biomarkers Predict Cerebral Palsy and Cognitive Delay in Hypoxic-Ischemic Encephalopathy: A Secondary Analysis of the HEAL Randomized Controlled Trial.

The Journal of pediatrics·2026
Same journal

Does Mild Head Injury in Childhood Affect Later School Performance? A Sibling Comparison Cohort Study.

The Journal of pediatrics·2026
See all related articles

Soluble CD40 ligand (sCD40L) levels are highest in neonates and remain elevated throughout childhood compared to adults. Age-specific reference ranges are crucial for evaluating sCD40L in pediatric conditions.

Area of Science:

  • Immunology
  • Pediatric Health
  • Biochemistry

Background:

  • Soluble CD40 ligand (sCD40L) plays a role in immune responses.
  • Understanding age-related variations in sCD40L is important for clinical interpretation.

Purpose of the Study:

  • To investigate age-dependent changes in sCD40L levels.
  • To establish reference ranges for sCD40L in healthy pediatric and adult populations.

Main Methods:

  • sCD40L was quantified using enzyme-linked immunosorbent assay (ELISA).
  • Participants included neonates, children (3 months-15 years), and adults.
  • Statistical analyses included Mann-Whitney tests and correlation coefficients.

Main Results:

  • Plasma sCD40L levels were significantly higher in neonates and pediatric groups compared to adults.

Related Experiment Videos

  • No significant differences were observed between pediatric age subgroups.
  • Serum sCD40L was highest in neonates but showed no significant difference between pediatric and adult groups.

    • Conclusions:

    • Plasma sCD40L levels exhibit a developmental trajectory, being highest at birth and remaining elevated through childhood.
    • Further research is needed to elucidate the reasons for these developmental changes.
    • Establishing age-appropriate reference ranges for sCD40L is recommended for pediatric evaluations.